Blood Plasma Derivatives Market Size & Share, By Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Others), Application (Haemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand’s Disease, Other), End-User (Hospitals, Clinics, Other End Users) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

Report ID: FBI 6052| Published Date: Jan-2025| Format: PDF, Excel
Jump to Content
Market Outlook

Market Size and Growth Outlook

Blood Plasma Derivatives Market size is expected to see substantial growth, increasing from USD 49.04 billion in 2024 to USD 111.9 billion by 2034, at a CAGR of over 8.6%. By 2025, the industry revenue is estimated to be USD 52.84 billion.

Base Year Value (2024)
USD 49.04 billion
CAGR (2025-2034)
8.6%
Forecast Year Value (2034)
USD 111.9 billion
Historical Data Period
2019-2024
Largest Region
North America
Forecast Period
2025-2034

Get more details on this report

Request Free Sample Report
Snapshot

Blood Plasma Derivatives Market Intelligence Snapshot

Regional Market Dynamics

Segment Momentum

Market Expansion Drivers

Leading Market Participants

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

Regional and Segment Outlook

Market Dynamics

Market Growth Drivers and Industry Trends

Growth Drivers & Opportunity: One significant growth driver for the Blood Plasma Derivatives Market is the increasing prevalence of hemophilia and other bleeding disorders. As awareness and diagnosis of these conditions improve, there is a growing demand for plasma-derived therapies that can effectively manage symptoms and enhance the quality of life for patients. With advancements in medical technology and research, new and improved therapies are being developed, leading to an expanded treatment landscape. This rising patient population is prompting healthcare providers to seek better treatment options, thereby boosting the demand for blood plasma derivatives. Moreover, a major contributor to the growth is the expanding application of blood plasma derivatives in various therapeutic areas beyond traditional uses. Plasma proteins such as immunoglobulins and clotting factors are increasingly being utilized in the treatment of autoimmune disorders, infections, and surgical procedures. The diversification of applications not only drives market growth through heightened demand but also attracts investments in research and development, fostering innovation within the industry. This broadening scope of usage supports a positive outlook for the market as new indications are explored and validated. However, one more driving factor is the supportive regulatory environment for blood plasma derivatives. Governments and health organizations are recognizing the therapeutic benefits of plasma-based treatments, leading to more favorable policies and streamlined approval processes. Regulatory agencies are working alongside manufacturers to ensure the safety and efficacy of these products, thereby enhancing public trust and encouraging uptake among healthcare providers. The favorable regulatory landscape is likely to fuel market growth by enabling quicker access to vital therapies for patients in need. Industry Restraints: Despite the positive outlook, the Blood Plasma Derivatives Market faces a significant restraint in the form of high manufacturing costs and supply chain complexities. Producing high-quality plasma derivatives involves advanced technology and stringent quality control, which can lead to expensive production processes. Moreover, the sourcing of human plasma can be challenging, particularly as demand increases. These factors may limit market growth, as manufacturers need to balance cost efficiency with the need to maintain product quality and safety. Another major restraint is the growing competition from alternative therapies. The development of recombinant therapies as substitutes for traditional plasma-derived products poses a challenge to the blood plasma derivatives market. These alternatives may offer advantages such as lower risk of transmission of infections and better targeted treatments, attracting attention from both healthcare providers and patients. As more innovations enter the market, the demand for traditional blood plasma derivatives may experience pressure, hindering the overall growth of the industry.

Explore Growth Opportunities

Request Free Sample Report
Regional Forecast

Regional Demand Dynamics

Blood Plasma Derivatives Market
Largest Region
North America
47% Market Share in 2024
In North America, the Blood Plasma Derivatives Market is experiencing steady growth due to the increasing prevalence of chronic diseases and advancements in healthcare infrastructure in countries like the U.S. and Canada. The rising demand for plasma-derived products for the treatment of immune deficiencies, hemophilia, and other rare diseases is also boosting market growth in the region. In Asia Pacific, countries like China, Japan, and South Korea are witnessing rapid growth in the Blood Plasma Derivatives Market. This can be attributed to the increasing healthcare expenditure, rising awareness about plasma therapies, and a large patient pool in these countries. The growing geriatric population and improving access to healthcare services are further driving the market growth in the region. In Europe, the Blood Plasma Derivatives Market is well-established, with countries like the United Kingdom, Germany, and France leading the market. The presence of key market players, favorable government initiatives, and increasing R&D investments are propelling market growth in the region. Additionally, the growing adoption of plasma-derived products for the treatment of autoimmune disorders and genetic diseases is contributing to the market expansion in Europe.
🔒 Need data on a specific country or region? Individual country/region reports are available at discounted pricing. Inquire Before Buying

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Blood Plasma Derivatives Market By Type: Albumin segment is expected to dominate the market due to its wide range of applications in treating various medical conditions such as burns, liver diseases, and hypoalbuminemia. Factor VIII is anticipated to witness significant growth owing to the increasing prevalence of hemophilia A and the growing demand for factor VIII concentrates. Factor IX segment is projected to grow steadily due to the rising prevalence of hemophilia B and the adoption of factor IX products for the treatment of the disease. Immunoglobulin segment is expected to witness substantial growth due to the increasing prevalence of immunodeficiency diseases and the rising demand for immunoglobulin products for the treatment of these conditions. Hyperimmune globulin segment is expected to grow at a rapid pace owing to its effectiveness in treating certain infectious diseases and its increasing adoption in clinical settings. Others segment is projected to witness moderate growth due to the rising demand for other blood plasma derivatives for the treatment of various medical conditions. Blood Plasma Derivatives Market By Application: Haemophilia segment is expected to dominate the market due to the high prevalence of hemophilia and the growing demand for blood plasma derivatives for the treatment of the disease. Hypogammaglobulinemia segment is anticipated to witness significant growth owing to the increasing prevalence of the condition and the rising demand for immunoglobulin products for its treatment. Immunodeficiency diseases segment is projected to grow steadily due to the rising prevalence of various immunodeficiency diseases and the increasing adoption of blood plasma derivatives for their treatment. Von Willebrand's Disease segment is expected to witness substantial growth due to the high prevalence of the disease and the growing demand for factor VIII concentrates for its treatment. Other segment is expected to witness moderate growth due to the increasing adoption of blood plasma derivatives for the treatment of various other medical conditions. Blood Plasma Derivatives Market By End-User: Hospitals segment is expected to dominate the market due to the high patient footfall in hospitals and the increasing use of blood plasma derivatives for the treatment of various medical conditions. Clinics segment is anticipated to witness significant growth owing to the rising number of clinics offering specialized treatment services and the increasing demand for blood plasma derivatives in clinical settings. Other end users segment is projected to grow steadily due to the increasing adoption of blood plasma derivatives in non-traditional healthcare settings such as home healthcare and ambulatory care centers.
Segment Sub-Segment Largest Segment Fastest Growing
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Competitive Landscape

Competitive Landscape and Market Positioning

The Blood Plasma Derivatives Market is characterized by a diverse landscape with key players competing to innovate and expand their product portfolios. The increasing prevalence of hemophilia, immune deficiencies, and other chronic diseases has propelled demand for plasma-derived products, attracting both established companies and new entrants into the market. Major players are focusing on strategic collaborations, research and development activities, and enhancing manufacturing capabilities to gain a competitive edge. Additionally, regulatory challenges and the need for high-quality standards continue to shape the dynamics of the market, leading to significant investment in technology and infrastructure. Top Market Players - Grifols S.A. - CSL Limited - Takeda Pharmaceutical Company Limited - Octapharma AG - Baxter International Inc. - Blood Products Laboratory - Biotest AG - Emergent BioSolutions Inc. - Shire plc - Kedrion S.p.A.
Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Blood Plasma Derivatives Market — Custom Segments

Segment Sub-Segment
No segment data available.

Blood Plasma Derivatives Market — Custom TOC

Custom Chapter Chapter Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
FAQ

Frequently Asked Questions

Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL
Healthcare & Medical Devices
Research Team Overview

This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team
10+Industry Verticals
100+Countries Analyzed
5-7Days Standard
Delivery
13.8K+Research Reports
Published
On-DemandCustomized Research
Available
6Months Analyst
Support
PDF + XLSReport Deliverables
Trust & Compliance
D&B D-U-N-S
GDPR & CCPA Compliant
ISO 9001 Certified (ISO 9001:2015)
SSL Encryption
Secure Payments
Confidential Handling
Research Intelligence
Primary Research Network
Secondary Sources
Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts
Research Workflow & Quality Assurance
01
Data Collection
Verified information gathered through primary and secondary research.
02
Data Triangulation
Cross-validation using multiple independent data sources.
03
Forecast Modelling
Market estimates developed using historical trends and analytical models.
04
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
05
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
06
Final Publication
Released after successful completion of the internal review process.
Report Coverage
Market Assessment
  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics
🏢 Competitive Intelligence
  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis
🚀 Future Outlook
  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →